-

NanoTemper Technologies Launches DLS Capability With Prometheus Panta, Bringing High-Resolution, Domain-Specific Stability Characterization to Biologics

Prometheus, the new gold standard, now provides clarity to the most challenging stability characterizations

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--NanoTemper Technologies, well-known for creating tools that address challenging characterizations, today introduced Prometheus Panta, a multi-parameter stability characterization instrument. By combining DLS for particle size determination with nanoDSF for thermal unfolding and backreflection for aggregation, researchers in biologics formulation optimization, developability, or comparability assessments will find that Prometheus Panta offers superior characterization of their candidate molecules.

“Inevitably, researchers will come across candidate molecules that present challenges. Here’s where Prometheus Panta shines, offering a solution they can rely on for clear, trustworthy, and high-resolution data for colloidal and conformational stability,” said Philipp Baaske, Co-CEO of NanoTemper.

Having the right technology really matters when researchers need to detect small differences or subtleties in unfolding events. Missing these details means handing over subpar candidates to teams working downstream — a costly mistake for drug pipelines.

“For the first time, researchers are able to correlate particle sizing, thermal unfolding and aggregation results collected throughout an entire thermal ramp,” comments Charles Heffern, Product Manager at NanoTemper. “This gives them a completely new perspective about stability attributes at the domain level that they would’ve otherwise missed.” Getting clear answers to questions — Which domains have a tendency to aggregate and at what temperature does this happen? Is the increase in particle size at a certain temperature due to an unfolding event for a particular domain? — are now possible.

Visit nanotempertech.com/prometheus-for-biologics to find out more details. For the most up-to-date information, follow NanoTemper on LinkedIn, Facebook, and Twitter.

About NanoTemper Technologies

Our mission at NanoTemper Technologies is to enable everyone to do science that matters by always pushing the limits. We’re focused on making tools that address challenging characterizations for use in drug discovery and basic science research. Working with scientists striving to make a difference in the world gets us excited. If you’re facing challenges with affinity screening, molecular interactions, protein stability, or protein quality, let’s talk.

Contacts

Jocelyn Davé
jocelyn.dave@nanotempertech.com
+1-415-316-6313

NanoTemper Technologies


Release Summary
NanoTemper launches DLS capability with Prometheus Panta, bringing high-resolution, domain-specific stability characterization to biologics

Contacts

Jocelyn Davé
jocelyn.dave@nanotempertech.com
+1-415-316-6313

More News From NanoTemper Technologies

NanoTemper Brings Spectral Shift Technology to the Protein Production Market With Andromeda X, Enabling Biopharma and CROs to Increase Efficiency of Expression Screening for Recombinant Protein Targets

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--NanoTemper Technologies, well known for creating biophysical tools that accelerate the work of drug discovery researchers, brings their groundbreaking Spectral Shift technology to the protein production market with the release of Andromeda X, an instrument that determines optimal expression alongside thermal stability of recombinant proteins in crude lysates. Andromeda X increases the efficiency of protein production teams at Biopharma and CROs, who...

NanoTemper Technologies Launches Human Fc Labeling Kit, Accelerating Biologics Affinity Screening Workflows

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--NanoTemper Technologies, creator of high-quality, easy-to-learn biophysical tools for drug discovery, launches a new way for biologics researchers to screen humanized antibody therapeutics with the release of their Human Fc Labeling Kit. Optimized for use with Spectral Shift technology, an in-solution affinity screening method, scientists looking for innovative ways to accelerate candidate selection will appreciate the ability to measure affinities...

NanoTemper Technologies Unveils Biotinylated Target Labeling Kit, Empowering Scientists in Pharma Industry to Tackle Challenging Drug Targets

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--NanoTemper Technologies, creator of biophysical tools for drug discovery, today, proudly announced the launch of their highly anticipated Biotinylated Target Labeling Kit, expanding the molecular interaction analysis toolkit for scientists working with complex or undruggable targets, filling a vital gap in screening and hit validation workflows in the pharma industry. This new kit combined with NanoTemper’s exclusive Spectral Shift technology is the...
Back to Newsroom